US 9724411
Methods for treating hypercholesterolemia and reducing LDL-C using antibodies to PCSK9
granted A61KA61K2039/505A61K2039/545
Quick answer
US patent 9724411 (Methods for treating hypercholesterolemia and reducing LDL-C using antibodies to PCSK9) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Aug 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 32
- CPC classes
- A61K, A61K2039/505, A61K2039/545, A61K31/40, A61K39/3955